Cardiac Imaging
July 16, 2026
Zero CAC And The Cost of CCTA-QPA July 16, 2026
The power of a zero CAC score is facing fresh scrutiny after new plaque analysis data presented at SCCT 2026 shows just how much noncalcified plaque confers its own cardiovascular risk, despite the software’s financial barriers.
Pharmaceuticals
July 12, 2026
CARDIO-TTRansform and The Future of ATTR-CM Drugs July 12, 2026
The ATTR-CM drug race almost got another contender, but AstraZeneca and Ionis' Wainua unexpected Phase 3 trial failure might have actually simplified the field.
Heart Failure
July 9, 2026
POLY-HF and the Possibility of HF Polypills July 9, 2026
Guideline-directed heart failure therapy works, but the biggest hurdle is getting patients to actually take it and fresh results in Nature from the POLY-HF trial suggest a polypill approach could be the answer.